Natalia Zarate-Lopez
Overview
Explore the profile of Natalia Zarate-Lopez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Butt M, Groen J, Jonker C, Burton-Murray H, Carrington E, Chang L, et al.
Neurogastroenterol Motil
. 2024 Jul;
36(10):e14869.
PMID: 39038114
Transition services-programs that support adolescents and young adults (AYAs) as they move from a child-centered to a more autonomous, adult-orientated healthcare system-have been associated with improved short- and long-term healthcare...
2.
Topan R, Pandya S, Williams S, Ruffle J, Zarate-Lopez N, Aziz Q, et al.
Am J Gastroenterol
. 2023 Nov;
119(4):727-738.
PMID: 37970870
Introduction: Disorders of gut-brain interaction (DGBI) are common in patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder (hEDS/HSD). Food is a known trigger for DGBI symptoms, which often leads to dietary...
3.
Hubbard R, Brooks A, Arebi N, El-Khouly S, Kiparissi F, Mozdiak E, et al.
Frontline Gastroenterol
. 2023 Oct;
14(6):491-496.
PMID: 37854783
Objective: To explore Young Persons (YP) and healthcare professionals (HCP) experiences of virtual consultations (VC) and establish whether developmentally appropriate healthcare can be delivered virtually. Method: YP and HCP questionnaire...
4.
Dervin H, Zarate-Lopez N, Sweis R, Mensah A, Fragkos K, Brugaletta C, et al.
Neurogastroenterol Motil
. 2023 Mar;
35(9):e14570.
PMID: 36989174
Background: Using hydrogen breath testing (HBT) to diagnose small intestinal bacterial overgrowth (SIBO) remains controversial in patients with functional gastrointestinal (GI) disorders, and unknown in those with hypermobility Ehlers-Danlos syndrome...
5.
Lam C, Amarasinghe G, Zarate-Lopez N, Fikree A, Byrne P, Kiani-Alikhan S, et al.
Frontline Gastroenterol
. 2022 Dec;
14(1):68-77.
PMID: 36561778
Patients diagnosed with hypermobile Ehlers-Danlos syndrome and hypermobile spectrum disorders are increasingly presenting to secondary and tertiary care centres with gastrointestinal (GI) symptoms and nutritional issues. Due to the absence...
6.
Gollifer R, Taylor S, Menys A, Zarate-Lopez N, Chatoor D, Emmanuel A, et al.
Neurogastroenterol Motil
. 2022 Apr;
34(10):e14381.
PMID: 35438218
Background: Gastrointestinal symptoms in functional gut disorders occur without any discernible structural gut abnormality. Preliminary observations on enteric MRI suggest possible abnormal content and motility of the terminal ileum (TI)...
7.
Lambarth A, Zarate-Lopez N, Fayaz A
Neurogastroenterol Motil
. 2021 Nov;
34(1):e14289.
PMID: 34755926
Background: Irritable bowel syndrome (IBS) is a highly prevalent and economically burdensome condition; and pain is often the most unpleasant, disruptive, and difficult-to-treat symptom. Visceral hypersensitivity is a common feature...
8.
Miller C, Emmanuel A, Zarate-Lopez N, Taylor S, Bloom S
Frontline Gastroenterol
. 2021 Oct;
12(6):493-499.
PMID: 34712467
Clinical experience suggests that there is a cohort of patients with refractory colitis who do have faecal stasis that contributes to symptoms. The underlying physiology is poorly understood, partly because...
9.
Chan M, Zarate-Lopez N, Martin L
J Hum Nutr Diet
. 2021 Oct;
35(3):425-434.
PMID: 34705305
Background: The low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet is an effective dietitian-led treatment for irritable bowel syndrome (IBS). An increasing demand of IBS patient referrals has warranted...
10.
Daly M, Zarate-Lopez N
Clin Med (Lond)
. 2021 Aug;
21(5):e480-e486.
PMID: 34385299
This article offers a framework in history taking for functional gastrointestinal disorders (FGIDs). Clinicians rely on history taking and knowledge of the latest 'Rome IV criteria' rather than biomarkers to...